Brian Mueller, EVP, Chief Financial Officer at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 14,002 shares at $104.50 ($1.5M) on 2022-12-02, disclosed to the SEC on 2022-12-06.
Open-market sale of $1.5M BMRN by EVP, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $104.50 | 1,101 | $115K | 7.9% |
| 2 | $104.50 | 1,101 | $115K | 7.9% |
| 3 | $104.50 | 2,139 | $224K | 15.3% |
| 4 | $104.50 | 2,139 | $224K | 15.3% |
| 5 | $104.50 | 3,761 | $393K | 26.9% |
| 6 | $104.50 | 3,761 |
| $393K |
| 26.9% |
| Total | $104.50 avg | 14,002 | $1.5M | 100% |
| Filing → |
| BMRN | SELL | 2022-12-15 | $269K | — | Filing → |
| BMRN | SELL | 2022-11-28 | $714K | — | Filing → |
| BMRN | SELL | 2022-08-09 | $331K | — | Filing → |